Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

The role of probiotics and prebiotics in modulating of the gut-brain axis Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

December 28, 2025

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-12-28

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This review explored the role of probiotics and prebiotics in modulating the gut-brain axis and their effects on central nervous system (CNS) disorders, including depression, anxiety, schizophrenia, autism, and Alzheimer’s. The research investigates the mechanisms through which these compounds affect the gut microbiota, brain function, and mental health.

Who was reviewed?

The review examined the effects of probiotics and prebiotics on mental health, focusing on their influence on the gut-brain axis and CNS disorders. It assessed various studies that explore how these dietary supplements can modulate gut microbiota, reduce inflammation, and improve brain functions, thereby aiding in the prevention and treatment of mental disorders.

What were the most important findings?

The review highlighted that probiotics and prebiotics can significantly influence the gut-brain axis by improving gut microbiota composition and function, leading to positive effects on mental health. Probiotics, particularly Lactobacillus and Bifidobacterium, can enhance neurotransmitter production, such as serotonin and GABA, which are critical for mood regulation. Prebiotics like inulin, FOS, and GOS stimulate the growth of beneficial gut bacteria and promote the production of short-chain fatty acids (SCFAs) such as butyrate, which have neuroprotective effects. The review found that these compounds can reduce systemic inflammation, regulate the hypothalamic-pituitary-adrenal axis, and decrease the severity of mental disorders such as depression and anxiety. However, the review stresses the need for further human studies to confirm these effects and establish clear therapeutic applications.

What are the implications of this study?

The findings underscore the potential of probiotics and prebiotics as a therapeutic and supportive approach to managing mental health conditions. By improving gut microbiota balance, these compounds can offer a natural, low-risk alternative to pharmaceutical treatments for mental disorders, particularly in cases where traditional treatments are insufficient or carry side effects. Future research, especially clinical trials, is crucial to determine the optimal strains and dosages for specific mental health conditions and to validate the long-term benefits of these supplements in psychiatric care.

Probiotics

Probiotics are live microorganisms that offer significant health benefits when administered in adequate amounts. They primarily work by modulating the gut microbiome, supporting a balanced microbial ecosystem. Probiotics have been shown to improve gut health, modulate immune responses, and even influence metabolic and mental health disorders. With growing evidence supporting their therapeutic potential, probiotics are increasingly recognized for their role in treating conditions like irritable bowel syndrome (IBS), antibiotic-associated diarrhea (AAD), and even mental health conditions like depression and anxiety through their impact on the gut-brain axis.

Prebiotics

Prebiotics are non-digestible fibers that selectively promote the growth of beneficial gut bacteria, offering a range of health benefits from improved digestion and immune function to enhanced metabolic health. Prebiotics are an essential part of a healthy diet that supports both gut and overall well-being.

Short-chain Fatty Acids (SCFAs)

Short-chain fatty acids are microbially derived metabolites that regulate epithelial integrity, immune signaling, and microbial ecology. Their production patterns and mechanistic roles provide essential functional markers within microbiome signatures and support the interpretation of MBTIs, MMAs, and systems-level microbial shifts across clinical conditions.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.